​

Eikon Therapeutics Ownership | Who Owns Eikon Therapeutics?

OverviewFinancialsChart

Eikon Therapeutics Ownership Summary

Eikon Therapeutics is owned by 49.29% institutional investors, 17.38% insiders, and 33.34% retail investors. Jane street group is the largest institutional shareholder, holding 0% of EIKN shares. BGF World Healthscience A2 is the top mutual fund, with 2.81% of its assets in Eikon Therapeutics shares.

EIKN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEikon Therapeutics49.29%17.38%33.34%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Jane street group---
Blackstone---
Landscape capital management---
Ghisallo capital management---
Lmr partners llp---
Squarepoint ops---
Wellington management group llp---
Hudson bay capital management lp---
Quantbot technologies lp---
Axq capital, lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Jane street group---
Blackstone---
Landscape capital management---
Ghisallo capital management---
Lmr partners llp---
Squarepoint ops---
Wellington management group llp---
Hudson bay capital management lp---
Quantbot technologies lp---
Axq capital, lp---

Top Buyers

HolderShares% AssetsChange
Quantbot technologies lp---1.10K
Landscape capital management---10.38K
Hudson bay capital management lp---13.48K
Axq capital, lp---15.41K
Squarepoint ops---30.98K

Top Sellers

HolderShares% AssetsChange
Jane street group---265.00K
Wellington management group llp---185.00K
Blackstone---168.34K
Goldman sachs group---129.31K
Lmr partners llp---115.00K

Sold Out

HolderChange
Quantbot technologies lp-1.10K
Landscape capital management-10.38K
Hudson bay capital management lp-13.48K
Axq capital, lp-15.41K
Squarepoint ops-30.98K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20267850.00%26,687,46212.40%492.56%555.77%9-
Mar 31, 202652-23,743,113-43-52---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
BGF World Healthscience A21.52M2.81%-
Fidelity Contrafund1.27M2.35%-1.10K
Fidelity Select Biotechnology1.15M2.13%54.20K
American Funds SMALLCAP World A1.14M2.11%-
T. Rowe Price Small-Cap Value848.85K1.57%-7.78K
Fidelity Growth Compy Commingled Pl S839.77K1.55%34.50K
T. Rowe Price New Horizons831.00K1.53%-27.72K
iShares Russell 2000 ETF819.31K1.51%7.01K
BlackRock Health Sciences Opps Inv A722.39K1.33%-
T. Rowe Price Health Sciences720.54K1.33%1.00

EIKN Ownership FAQ

Who Owns Eikon Therapeutics?

Eikon Therapeutics shareholders are primarily institutional investors at 49.29%, followed by 17.38% insiders and 33.33% retail investors. The average institutional ownership in Eikon Therapeutics's industry, Biotech Stocks , is 380.48%, which Eikon Therapeutics falls below.

Who owns the most shares of Eikon Therapeutics?

Eikon Therapeutics’s largest shareholders are Jane street group (0 shares, 0%), Blackstone (0 shares, 0%), and Landscape capital management (0 shares, 0%). Together, they hold 0% of Eikon Therapeutics’s total shares outstanding.

Does Blackrock own Eikon Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Eikon Therapeutics.

Who is Eikon Therapeutics’s biggest shareholder by percentage of total assets invested?

Jane street group is Eikon Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Eikon Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Eikon Therapeutics shares?

BGF World Healthscience A2 is the top mutual fund holder of Eikon Therapeutics shares, with 2.81% of its total shares outstanding invested in 1.52M Eikon Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools